Juvenile Rheumatoid Arthritis Clinical Trial
Official title:
Effect of Electroacupuncture Versus Phonophoresis on Refractory Pain in Juvenile Rheumatoid Arthritis
the purpose of the study is to investigate the effect of Electrical Acupuncture Versus naproxen phonophoresis on Refractory pain in Juvenile Rheumatoid arthritis
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children and adolescents, affecting approximately one in 1000 children in North America. It is diagnosed in children younger than 16 years of age with arthritis in one or more joints for at least six weeks after other causes have been excluded. Arthritis in JIA is characterized by stiffness, pain and swelling of affected joints. The disease course of JIA may involve flares of increased disease activity or chronic persistent joint inflammation, even into adulthood. Various complications may arise secondary to ongoing disease activity or treatment, including joint damage and deformity, growth abnormalities and osteoporosis with fragility fractures The prevalence of refractory pain in children with arthritis is of particular concern because it often contributes to poor physical and psychosocial outcomes. Increased daily symptoms of pain predict considerable functional disability, including significantly reduced participation in school, social and physical activities, and augmented mood disturbance ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00004420 -
Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis
|
N/A | |
Completed |
NCT00090571 -
Juvenile Rheumatoid Arthritis Research Registry
|
||
Recruiting |
NCT05545839 -
Transition to Adulthood Through Coaching and Empowerment in Rheumatology
|
N/A | |
Completed |
NCT00010335 -
Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
|
Phase 1 | |
Completed |
NCT00690573 -
Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT00443430 -
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
|
Phase 4 | |
Completed |
NCT03780959 -
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT00006055 -
Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
|
N/A | |
Completed |
NCT00570934 -
Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA
|
Phase 3 | |
Recruiting |
NCT05715463 -
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
|
N/A | |
Completed |
NCT00289094 -
Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA
|
N/A | |
Terminated |
NCT00078806 -
Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT00078793 -
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
|
N/A | |
Completed |
NCT00000429 -
Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis
|
Phase 2 | |
Completed |
NCT01044823 -
Use of Thermal and 3D Imaging to Quantify Arthritis
|
N/A | |
Terminated |
NCT00029042 -
Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
|
Phase 2 | |
Withdrawn |
NCT00286689 -
Effects of Growth Hormone in Chronically Ill Children
|
N/A | |
Completed |
NCT00095173 -
BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT00001862 -
TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
|
Phase 2 | |
Not yet recruiting |
NCT05114343 -
Effectiveness and Feasibility of a Home-based Exercise Program for Adolescents With Juvenile Idiopathic Arthritis
|
N/A |